Question 1

What evidence establishes a converted identity?

Accepted Answer

Transcriptome-wide comparison against the authentic target cell type, evidence that the starting programme has been silenced, and where possible a functional assay. Marker gene expression alone is insufficient, since partially converted cells frequently acquire markers without acquiring function or losing their original identity.

Question 2

How is a minimal factor set actually found?

Accepted Answer

By systematic removal from a working cocktail, testing each subset for conversion. Starting with a large set that works and reducing it is more tractable than building up. Reporting which factors proved dispensable is as informative as reporting the final set, and it is often omitted.

Question 3

Why does low efficiency matter methodologically?

Accepted Answer

Because population-level measurements are dominated by unconverted cells when conversion is rare. Bulk transcriptomics on a mixed population can obscure both success and failure, so single-cell measurement or lineage tracing to identify converted cells becomes necessary rather than optional at typical efficiencies.

Question 4

Is direct conversion preferable to going via pluripotency?

Accepted Answer

It depends on the goal. Direct conversion avoids a proliferative intermediate and is faster, but is generally less efficient and less predictable. Routes through pluripotency are better characterised and more scalable. Stating which trade-off drove the choice is part of a defensible methods rationale.

Question 5

How should partially converted cells be handled?

Accepted Answer

As a finding, not a contamination problem. Cells stalling between identities reveal which steps in the conversion are limiting, and characterising them often teaches more than the fully converted population alone. Excluding them silently from the analysis removes the most informative part of the result.

Question 6

What role does chromatin state play?

Accepted Answer

A substantial one. The accessibility of target loci in the starting cell determines which factors can act, which is why the same cocktail behaves differently across starting cell types. Recording the starting cell type precisely, and not generalising results across sources, matters more here than in many areas.

Question 7

Can candidate factors be predicted computationally?

Accepted Answer

Partly. Expression and regulatory network analysis narrows the candidate list usefully, but predictions of which combinations will work remain unreliable, which is why screening persists. Using computation to prioritise, then reporting how well the prioritisation performed, is more honest than presenting it as a selection method.

Biotechnology

Biotechnology

Research Frontiers in Cellular Reprogramming Factor Identification